| Over the past | Total investment | Would've become | Historic returns | Returns |
|---|---|---|---|---|
| 3 months | ₹15,000 | ₹15,699 | +4.66% | |
| 6 months | ₹30,000 | ₹33,479 | +11.60% | |
| 1 year | ₹60,000 | ₹70,578 | +17.63% |
| Name | Sector | Instruments | Assets |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 10.86% |
| Divi's Laboratories Ltd | Healthcare | Equity | 10.35% |
| Torrent Pharmaceuticals Ltd | Healthcare | Equity | 9.38% |
| Aster DM Healthcare Ltd | Healthcare | Equity | 6.21% |
| Max Healthcare Institute Ltd | Healthcare | Equity | 5.86% |
| Ajanta Pharma Ltd | Healthcare | Equity | 5.20% |
| Mankind Pharma Ltd. | Healthcare | Equity | 4.66% |
| Others CBLO | Unspecified | CBLO | 4.32% |
| Dr. Lal Pathlabs Ltd | Healthcare | Equity | 4.05% |
| Krishna Institute Of Medical Sciences Ltd | Healthcare | Equity | 3.77% |
| Rubicon Research Ltd. | Healthcare | Equity | 3.68% |
| Abbott India Ltd | Healthcare | Equity | 3.23% |
| Neuland Laboratories Ltd | Healthcare | Equity | 3.03% |
| Navin Fluorine International Ltd | Materials | Equity | 2.81% |
| Sai Life Sciences Ltd. | Healthcare | Equity | 2.56% |
| Cipla Ltd | Healthcare | Equity | 2.39% |
| Pfizer Ltd | Healthcare | Equity | 2.25% |
| Jupiter Life Line Hospitals Ltd. | Healthcare | Equity | 2.23% |
| Anthem Biosciences Ltd. | Healthcare | Equity | 1.99% |
| Global Health Ltd | Healthcare | Equity | 1.83% |
| Zydus Lifesciences Ltd | Healthcare | Equity | 1.35% |
| Fortis Healthcare Ltd | Healthcare | Equity | 1.28% |
| Lupin Ltd | Healthcare | Equity | 1.23% |
| Manipal Health Enterprises Ltd | Healthcare | Equity | 0.96% |
| Orchid Pharma Ltd | Healthcare | Equity | 0.91% |
| Dr. Agarwal’S Health Care Ltd. | Healthcare | Equity | 0.90% |
| ICICI Lombard General Insurance Company Ltd | Financial | Equity | 0.89% |
| Lenskart Solutions Ltd. | Consumer Discretionary | Equity | 0.68% |
| Sagility India Ltd. | Industrials | Equity | 0.48% |
| Dr. Agarwals Eye Hospital Ltd | Healthcare | Equity | 0.45% |
| Net Receivables | Unspecified | Net Receivables | 0.21% |
| Name | 3M | 6M | 1Y | All |
|---|---|---|---|---|
| Fund returns | +11.2% | +22.6% | +20.4% | +20.9% |
| Category average (Equity Sectoral) | -- | -- | -2.1% | -- |
| Rank (Equity Sectoral) | 2 | 4 | 3 | -- |